JENBURKT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2024 inter alia to consider and approve the standalone unaudited financial results of the Company for the quarter ended on 30th June 2024.